INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca.
INFER: Masterclasses in NF
INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis and schwannomatosis experts.
View upcoming topics/speakers, register, or watch recordings of past events below.
![International nfe educational resources logo.](https://www.ctf.org/wp-content/uploads/2023/12/CTF-Infer_logo.png)
Upcoming Events
Live classes will only be held in English. Recordings of sessions translated to additional languages will be published when available.
Treatment Strategies for Vestibular Schwannomas: When to Treat? How to Treat?
September 12, 2024
5:00 pm CET (Brussels time)
Lecturer: Michel Kalamarides, MD, PhD Pitié-Salpêtrière Hospital; Sorbonne University, Paris, France
![Promotional banner for "Masterclasses in NF" on treatment strategies for vestibular schwannomas on September 12, 2024, featuring Michel Kalamarides, MD, PhD, organized by INFER.](https://www.ctf.org/wp-content/uploads/2024/06/IMG_3968.jpg)
Recordings of Past Events
Plexiform Neurofibromas in NF1 - General Course and Neuroradiology
Jan 24, 2024
![Infer Masterclasses Speaker Hector Salvador](https://www.ctf.org/wp-content/uploads/2023/12/infer-jan2024-hector-salvador-1.jpeg)
Dr. Hector Salvador, MD
Sant Joan de Deu Barcelona Children’s Hospital
![Infer Masterclasses Speaker Gregor Kasprian](https://www.ctf.org/wp-content/uploads/2023/12/infer-jan2024-gregor-kasprian-1.jpeg)
Assoc. Prof. Dr. Gregor Kasprian
Medical University of Vienna
Ophthalmologic Findings and Orthopic Eye Examination in NF1 and NF2-Related Schwannomatosis
Dec 12, 2023
![](https://www.ctf.org/wp-content/uploads/2023/12/Sabine_Koinig.jpg)
OT Sabine Koinig
Medical University of Vienna
![](https://www.ctf.org/wp-content/uploads/2023/12/Berthold_Pemp.jpg)
Prof. Dr. Berthold Pemp
Medical University of Vienna
Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome
Nov 9, 2023
![Infer Masterclasses Speaker Katharina Wimmer](https://www.ctf.org/wp-content/uploads/2023/12/infer-nov2023-katharina-wimmer.jpg)
Prof. Dr. Katharina Wimmer
Medical University of Innsbruck
Rare NF1-Associated Tumors in Adults
Oct 23, 2023
![](https://www.ctf.org/wp-content/uploads/2023/12/Eric-Legius.jpg)
Eric Legius, MD, PHD
University Hospital of Leuven, Belgium
![](https://www.ctf.org/wp-content/uploads/2023/12/Ellen-Denayer.jpg)
Prof. Ellen Denayer
University Hospital Leuven
Optimising Hearing Outcomes in NF2-Related Schwannomatosis
Oct 2, 2023
![](https://www.ctf.org/wp-content/uploads/2023/12/Simon-Freeman.jpg)
Simon Freeman, MPhil FRCS
Manchester Royal Infirmary and Salford Royal Hospital
NF1 Dermatological Manifestations
May 23, 2023
![](https://www.ctf.org/wp-content/uploads/2023/12/PIerre_Wolkenstein.jpg)
Pierre Wolkenstein, MD, PhD
Hopital Henri-Mondor, Paris, France
![](https://www.ctf.org/wp-content/uploads/2023/12/Laura-Fertitta.jpg)
Laura Fertitta, MD
Hôpital Universitaire Henri Mondor
![](https://www.ctf.org/wp-content/uploads/2023/12/Sirkku_Peltonen.jpg)
Sirkku Peltonen, MD, PhD
University of Gothenberg, Sweden
Breast Cancer in NF1
Mar 23, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Gareth-Evans.jpg)
Gareth Evans, MD
University of Manchester, UK
NF1 Pre-Implantation Genetic Diagnosis
Apr 20, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Eric-Legius.jpg)
Eric Legius, MD, PHD
University Hospital of Leuven, Belgium
![](https://www.ctf.org/wp-content/uploads/2023/12/Ellen-Denayer.jpg)
Prof. Ellen Denayer
University Hospital Leuven
Pain in Non-NF2-Related Schwannomatosis
Oct 28, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/David-Pang.jpg)
David Pang, MD, ChB.
Guys and St Thomas’ Hospital NHS Trust, London
Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches
Oct 28, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Michel_Kalamarides.jpg)
Said Farschtschi, MD
University Medical Center
Hamburg-Eppendorf, Germany
Surgery in NF2
Apr 15, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Michel_Kalamarides.jpg)
Michel Kalamarides, MD, PhD
Hôpital Pitié-Salpêtrière , Paris, France
![](https://www.ctf.org/wp-content/uploads/2023/12/Andrew-King.jpg)
Andrew King, MBBS FRCS FRCS(SN)
Salford Royal Hospital, Manchester, United Kingdom
Cognition and Behaviour in NF1: Phenotype and Treatment Approaches
Mar 17, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Shruti-Garg.jpg)
Shruti Garg, MBBS, MRCPsych, MMedSci, PhD
Royal Manchester Children’s Hospital, United Kingdom
![](https://www.ctf.org/wp-content/uploads/2023/12/Andre_Rietman.jpg)
Andre Rietman, PhD
Erasmus University Medical Center
Rotterdam, Netherlands
Emotional Challenges in NF1, NF2 and Schwannomatosis
Feb 17, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Susie_Henley.jpg)
Susie Henley, DClinPsy, PhD
Guy’s and St Thomas’ NHS Foundation Trust, London UK
![](https://www.ctf.org/wp-content/uploads/2023/12/Thomas-Pletschko.jpg)
Thomas Pletschko, PhD
Medical University of Vienna, Austria
NF1 Pediatric Management
Jan 28, 2022
![](https://www.ctf.org/wp-content/uploads/2023/12/Rianne-Oostenbrink.jpg)
Rianne Oostenbrink, MD, PhD
Erasmus University Medical Center
Rotterdam, Netherlands
NF1 Associated Glioma in Children - the Optic Pathway and Beyond
Dec 10, 2021
![](https://www.ctf.org/wp-content/uploads/2023/12/Amedeo-Azizi.jpg)
Amedeo Azizi, MD, PhD
Medical University of Vienna, Austria
Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program
NF1 Orthopedic Manifestations
Nov 9, 2021
![](https://www.ctf.org/wp-content/uploads/2023/12/Eric-Legius.jpg)
Eric Legius, MD, PhD
University Hospital of Leuven, Belgium
Head of Clinical Genetics Department of the University Hospital Leuven
![](https://www.ctf.org/wp-content/uploads/2023/12/Christophe-Glorion.jpg)
Christophe Glorion, MD, PhD
Hopital Necker-Enfants Malades, Paris, France
Department of Paediatric Orthopedic and Traumatologic Surgery
NF1 Cutaneous Neurofibromas
Oct 6, 2021
![](https://www.ctf.org/wp-content/uploads/2023/12/PIerre_Wolkenstein.jpg)
Pierre Wolkenstein, MD, PhD
Hopital Henri-Mondor, Paris, France
Head of the Department of Dermatology
![](https://www.ctf.org/wp-content/uploads/2023/12/Sirkku_Peltonen.jpg)
Sirkku Peltonen, MD, PhD
University of Gothenberg, Sweden
Professor of Dermatology
NF1 Malignant Peripheral Nerve Sheath Tumors
Oct 25, 2021
![](https://www.ctf.org/wp-content/uploads/2023/12/Ferner_Rosalie.jpg)
Rosalie Ferner, MD
King’s College, London, UK
Neurologist at Guy’s and St Thomas’ NHS Foundation Trust
![](https://www.ctf.org/wp-content/uploads/2023/12/Mautner_Victor-Portratfoto_neu_klein_18.06.12.jpg)
Viktor-Felix Mautner, MD, PhD
University Medical Center in Hamburg-Eppendorf, Germany
Head of NF Outpatient Department